Sanjivani Paranteral

Stock Price vs Company Growth
1d
2.1%
1w
0.5%
1m
1.1%
3m
10.7%
6m
37.8%
1y
31.9%
5y
46.9%
10y
19.3%
all
8.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 149 2.1%
126
186
Company Overview

Sales
68.7 Cr
Growth: 13.2%
Profit after Tax
6.79 Cr
Growth: -17.9%
Micro Cap
183 Cr
P/E: 27.4x
Industry P/E: 33.7x
Fundamentals

Sales (Cr) ₹ 68.7
Growth 13.2%
EBITDA 15.0%
P/S 2.7x
Dividend 0.2%
P/E 27.4x
Book Value ₹ 39.3
PEG Ratio 2.1x
ROE 15.1%
P/B 3.9x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Sanjivani Parenteral was established in 1997 by A H Khemka, Ashwin Khemka and Somesh Khemka, under the technical direction of Mahendra Kalwankar. It is a research-based, international pharmaceutical company that provides a wide range of high quality products and services at affordable prices. The core product range of the company’s products includes oral solids, small volume parenterals and sterile powder formulations.
Investors (3)